116 related articles for article (PubMed ID: 24217105)
1. General practitioners' challenges during the 2009/A/H1N1 vaccination campaigns in Australia, Israel and England: a qualitative study.
Kunin M; Engelhard D; Thomas S; Ashworth M; Piterman L
Aust Fam Physician; 2013 Nov; 42(11):811-5. PubMed ID: 24217105
[TBL] [Abstract][Full Text] [Related]
2. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?
Schwarzinger M; Verger P; Guerville MA; Aubry C; Rolland S; Obadia Y; Moatti JP
Vaccine; 2010 Mar; 28(15):2743-8. PubMed ID: 20117271
[TBL] [Abstract][Full Text] [Related]
3. Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.
Flicoteaux R; Pulcini C; Carrieri P; Schwarzinger M; Leport C; Verger P
Vaccine; 2014 Apr; 32(20):2281-7. PubMed ID: 24631097
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the implementation of the H1N1 pandemic influenza vaccine in local health departments (LHDs) in North Carolina.
DiBiase LM; Davis SE; Rosselli R; Horney J
Vaccine; 2011 May; 29(23):3969-76. PubMed ID: 21477677
[TBL] [Abstract][Full Text] [Related]
5. Challenges and opportunities in the Israeli 2009 pandemic influenza vaccination program.
Levine H; Balicer RD; Laor D; Grotto I
Hum Vaccin; 2011 Oct; 7(10):1077-82. PubMed ID: 21941096
[TBL] [Abstract][Full Text] [Related]
6. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
7. Local health department public vaccination clinic success during 2009 pH1N1.
Klaiman T; Oʼconnell K; Stoto M
J Public Health Manag Pract; 2013; 19(4):E20-6. PubMed ID: 23722987
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.
Torun SD; Torun F
Vaccine; 2010 Aug; 28(35):5703-10. PubMed ID: 20600497
[TBL] [Abstract][Full Text] [Related]
9. Influenza pandemic 2009/A/H1N1 management policies in primary care: a comparative analysis of three countries.
Kunin M; Engelhard D; Thomas S; Ashworth M; Piterman L
Aust Health Rev; 2013 Jun; 37(3):291-9. PubMed ID: 23731961
[TBL] [Abstract][Full Text] [Related]
10. Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010.
Verger P; Flicoteaux R; Schwarzinger M; Sagaon-Teyssier L; Peretti-Watel P; Launay O; Sebbah R; Moatti JP
PLoS One; 2012; 7(8):e41837. PubMed ID: 22879896
[TBL] [Abstract][Full Text] [Related]
11. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
Wijnans L; Lecomte C; de Vries C; Weibel D; Sammon C; Hviid A; Svanström H; Mølgaard-Nielsen D; Heijbel H; Dahlström LA; Hallgren J; Sparen P; Jennum P; Mosseveld M; Schuemie M; van der Maas N; Partinen M; Romio S; Trotta F; Santuccio C; Menna A; Plazzi G; Moghadam KK; Ferro S; Lammers GJ; Overeem S; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
Vaccine; 2013 Feb; 31(8):1246-54. PubMed ID: 23246544
[TBL] [Abstract][Full Text] [Related]
12. Learning from successful school-based vaccination clinics during 2009 pH1N1.
Klaiman T; O'Connell K; Stoto MA
J Sch Health; 2014 Jan; 84(1):63-9. PubMed ID: 24320154
[TBL] [Abstract][Full Text] [Related]
13. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
14. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
[TBL] [Abstract][Full Text] [Related]
16. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
[TBL] [Abstract][Full Text] [Related]
17. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.
Bone A; Guthmann JP; Nicolau J; Lévy-Bruhl D
Vaccine; 2010 Nov; 28(51):8157-61. PubMed ID: 20937310
[TBL] [Abstract][Full Text] [Related]
18. Compliance with anti-H1N1 vaccine among healthcare workers and general population.
Blasi F; Aliberti S; Mantero M; Centanni S
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():37-41. PubMed ID: 22862684
[TBL] [Abstract][Full Text] [Related]
19. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.
Auriel E; Regev K; Dori A; Karni A
Muscle Nerve; 2011 Jun; 43(6):893-4. PubMed ID: 21607970
[TBL] [Abstract][Full Text] [Related]
20. The vaccination campaign against 2009 pandemic influenza A(H1N1) and its continued importance in view of the uncertainty surrounding the risk associated with the pandemic.
Tsiodras S; Sypsa V; Hatzakis A
Euro Surveill; 2010 Jan; 15(3):. PubMed ID: 20122377
[No Abstract] [Full Text] [Related]
[Next] [New Search]